A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases

Clinical trial NCT02780674 · COMPLETED

Trial details

NCT number: NCT02780674
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc

Start date: 2016-08-26
Primary completion: 2017-10-23
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.